Details
Stereochemistry | RACEMIC |
Molecular Formula | C14H12O3S |
Molecular Weight | 260.308 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C(O)=O)C1=CC=C(S1)C(=O)C2=CC=CC=C2
InChI
InChIKey=GUHPRPJDBZHYCJ-UHFFFAOYSA-N
InChI=1S/C14H12O3S/c1-9(14(16)17)11-7-8-12(18-11)13(15)10-5-3-2-4-6-10/h2-9H,1H3,(H,16,17)
Molecular Formula | C14H12O3S |
Molecular Weight | 260.308 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
Tiaprofenic acid is a non-steroidal, anti-inflammatory, analgesic compound, which nonselectively inhibits cyclooxygenase protein. Tiaprofenic acid was approved in Europe for the symptomatic relief of arthritis, ankylosing spondylitis and other inflammatory-rheumatic disorders as well as the painful conditions after injury.
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2094253 Sources: https://www.ncbi.nlm.nih.gov/pubmed/17652824 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Palliative | SURGAM Approved UseSymptomatic treatment of pain and inflammation in acute arthritis (including gout attack), chronic arthritis (rheumatoid arthritis in particular), ankylosing spondylitis and other inflammatory-rheumatic spinal disorders, irritation in degenerative joint and spine diseases (arthritis and spondylarthritis), inflammatory soft tissue rheumatic diseases, painful swelling or inflammation after injury. |
|||
Primary | SURGAM Approved UseSymptomatic treatment of pain and inflammation in acute arthritis (including gout attack), chronic arthritis (rheumatoid arthritis in particular), ankylosing spondylitis and other inflammatory-rheumatic spinal disorders, irritation in degenerative joint and spine diseases (arthritis and spondylarthritis), inflammatory soft tissue rheumatic diseases, painful swelling or inflammation after injury. |
|||
Palliative | SURGAM Approved UseSymptomatic treatment of pain and inflammation in acute arthritis (including gout attack), chronic arthritis (rheumatoid arthritis in particular), ankylosing spondylitis and other inflammatory-rheumatic spinal disorders, irritation in degenerative joint and spine diseases (arthritis and spondylarthritis), inflammatory soft tissue rheumatic diseases, painful swelling or inflammation after injury. |
PubMed
Title | Date | PubMed |
---|---|---|
Hepatotoxicity to several nonsteroidal anti-inflammatory drugs with diclofenac induced histological changes. | 1992 Mar |
|
Reinduction of the hypnotic effects of thiopental with NSAIDs by decreasing thiopental plasma protein binding in humans. | 1993 Apr |
|
Complementary deoxyribonucleic acid cloning and expression of a human liver uridine diphosphate-glucuronosyltransferase glucuronidating carboxylic acid-containing drugs. | 1993 Jan |
|
Retrospective analysis of drug-induced urticaria and angioedema: a survey of 2287 patients. | 2001 Nov |
|
[Photoaggravated contact allergy and contact photoallergy caused by ketoprofen: 19 cases]. | 2001 Oct |
|
[Tuberculous osteitis of the malar bone]. | 2002 |
|
Experimental study on phototoxicity and the photosensitization potential of ketoprofen, suprofen, tiaprofenic acid and benzophenone and the photocross-reactivity in guinea pigs. | 2002 Apr |
|
Differential effects of nonsteroidal antiinflammatory drugs on the IL-1 altered expression of plasminogen activators and plasminogen activator inhibitor-1 by articular chondrocytes. | 2002 Aug |
|
Use of the photo-micronucleus assay in Chinese hamster V79 cells to study photochemical genotoxicity. | 2002 Aug 26 |
|
Fixed drug eruption due to tiaprofenic acid. | 2002 Dec |
|
The role of the Australian Adverse Drug Reactions Advisory Committee (ADRAC) in monitoring drug safety. | 2002 Dec 27 |
|
[Results of a French nationwide survey of cutaneous side effects of ketoprofen gel reported between September 1996 and August 2000]. | 2002 Jan-Feb |
|
Do NSAIDs affect the progression of osteoarthritis? | 2002 Jun |
|
[Cross-reaction potentials of ketoprofen]. | 2002 May 12 |
|
[Photocontact dermatitis due to ketoprofen and photosensitization to tetrachlorosalicylanide and to Fenticlor(R)]. | 2002 Oct |
|
Indomethacin-induced morphologic changes in the rat urinary bladder epithelium. | 2003 Jan |
|
Thin layer chromatographic resolution of some 2-arylpropionic acid enantiomers using L-(-)-serine, L-(-)-threonine and a mixture of L-(-)-serine and L-(-)-threonine-impregnated silica gel as stationary phases. | 2003 Jul |
|
Risk of cancer in a large cohort of nonaspirin NSAID users: a population-based study. | 2003 Jun 2 |
|
The stereospecificity of flobufen metabolism in isolated guinea pig hepatocytes. | 2003 Jun 5 |
|
Spectrum of cross-photosensitization in 18 consecutive patients with contact photoallergy to ketoprofen: associated photoallergies to non-benzophenone-containing molecules. | 2003 Mar |
|
Evaluation of balhimycin as a chiral selector for enantioresolution by capillary electrophoresis. | 2004 Aug |
|
Risk of breast cancer among users of aspirin and other anti-inflammatory drugs. | 2004 Aug 2 |
|
Vehicle effects on in vitro release of tiaprofenic acid from different topical formulations. | 2004 Jul |
|
The modulation of intra-articular inflammation, cartilage matrix and bone loss in mono-articular arthritis induced by heat-killed Mycobacterium tuberculosis. | 2005 |
|
Long-term use of non-steroidal anti-inflammatory drugs and the risk of myocardial infarction in the general population. | 2005 Nov 29 |
|
Effects of co-administered dexamethasone and diclofenac potassium on pain, swelling and trismus following third molar surgery. | 2005 Nov 7 |
|
In vitro interactions of captopril with NSAID's. | 2006 Jul |
|
[Patterns of non steroidal anti-inflammatory drug use in ambulatory care]. | 2006 Mar-Apr |
|
Use of the yeast Saccharomyces cerevisiae as a pre-screening approach for assessment of chemical-induced phototoxicity. | 2006 Sep |
|
Activity and potential role of licofelone in the management of osteoarthritis. | 2007 |
|
Effectiveness of conservative treatments for the lumbosacral radicular syndrome: a systematic review. | 2007 Jul |
|
Upper gastrointestinal complications associated with NSAIDs in children. | 2007 Mar-Apr |
|
Acute NSAID-related transmural duodenitis and extensive duodenal ulceration. | 2007 Nov |
|
The pK(a) Distribution of Drugs: Application to Drug Discovery. | 2007 Sep 17 |
|
Nitric oxide and cardiovascular effects: new insights in the role of nitric oxide for the management of osteoarthritis. | 2008 |
|
The antiplatelet effect of six non-steroidal anti-inflammatory drugs and their pharmacodynamic interaction with aspirin in healthy volunteers. | 2008 Apr 1 |
|
Direct enantioselective HPLC monitoring of lipase-catalyzed kinetic resolution of tiaprofenic acid in nonstandard HPLC organic solvents. | 2008 Aug |
|
Cholesterol-diaryl ketone stereoisomeric dyads as models for "clean" type I and type II photooxygenation mechanisms. | 2008 Mar 7 |
|
The effects of etodolac, nimesulid and naproxen sodium on the frequency of sister chromatid exchange after enclused third molars surgery. | 2008 Oct 31 |
|
Phytalgic, a food supplement, vs placebo in patients with osteoarthritis of the knee or hip: a randomised double-blind placebo-controlled clinical trial. | 2009 |
|
Systematic review of the management of canine osteoarthritis. | 2009 Apr 4 |
|
Photodegradation mechanism of nonsteroidal anti-inflammatory drugs containing thiophene moieties: suprofen and tiaprofenic acid. | 2009 Aug 13 |
|
An exploration of the ability of tepoxalin to ameliorate the degradation of articular cartilage in a canine in vitro model. | 2009 Jul 22 |
|
Contact dermatitis due to topical drugs. | 2009 Oct |
|
Single dose oral tiaprofenic acid for acute postoperative pain in adults. | 2009 Oct 7 |
|
Aldosterone glucuronidation by human liver and kidney microsomes and recombinant UDP-glucuronosyltransferases: inhibition by NSAIDs. | 2009 Sep |
|
Hemorrhagic cystitis: A challenge to the urologist. | 2010 Apr |
|
Enhancement of antinociception by coadministration of minocycline and a non-steroidal anti-inflammatory drug indomethacin in naïve mice and murine models of LPS-induced thermal hyperalgesia and monoarthritis. | 2010 Dec 1 |
|
The effect of terpenes on percutaneous absorption of tiaprofenic acid gel. | 2010 Nov |
|
Screening of a chemical library reveals novel PXR-activating pharmacologic compounds. | 2015 Jan 5 |
Patents
Sample Use Guides
The recommended daily dose range for adults is 600 mg tiaprofen acid per day divided into 2 doses.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2754669
Human osteoarthritic cartilage was treated with therapeutic doses of tiaprofenic acid (26 micrograms/ml; 2.6 micrograms/ml) in order to test the effect of the drug on the proteoglycan metabolism (catabolism and synthesis) and chondrocyte ultrastructure. The drug suppresed the proteoglycan metabolism by 38%.
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:30:44 GMT 2023
by
admin
on
Fri Dec 15 15:30:44 GMT 2023
|
Record UNII |
1LS1T6R34C
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-VATC |
QM01AE11
Created by
admin on Fri Dec 15 15:30:44 GMT 2023 , Edited by admin on Fri Dec 15 15:30:44 GMT 2023
|
||
|
NCI_THESAURUS |
C257
Created by
admin on Fri Dec 15 15:30:44 GMT 2023 , Edited by admin on Fri Dec 15 15:30:44 GMT 2023
|
||
|
WHO-ATC |
M01AE11
Created by
admin on Fri Dec 15 15:30:44 GMT 2023 , Edited by admin on Fri Dec 15 15:30:44 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C90908
Created by
admin on Fri Dec 15 15:30:44 GMT 2023 , Edited by admin on Fri Dec 15 15:30:44 GMT 2023
|
PRIMARY | |||
|
618442
Created by
admin on Fri Dec 15 15:30:44 GMT 2023 , Edited by admin on Fri Dec 15 15:30:44 GMT 2023
|
ALTERNATIVE | |||
|
m10847
Created by
admin on Fri Dec 15 15:30:44 GMT 2023 , Edited by admin on Fri Dec 15 15:30:44 GMT 2023
|
PRIMARY | Merck Index | ||
|
1LS1T6R34C
Created by
admin on Fri Dec 15 15:30:44 GMT 2023 , Edited by admin on Fri Dec 15 15:30:44 GMT 2023
|
PRIMARY | |||
|
DTXSID5023665
Created by
admin on Fri Dec 15 15:30:44 GMT 2023 , Edited by admin on Fri Dec 15 15:30:44 GMT 2023
|
PRIMARY | |||
|
2652
Created by
admin on Fri Dec 15 15:30:44 GMT 2023 , Edited by admin on Fri Dec 15 15:30:44 GMT 2023
|
PRIMARY | |||
|
32221
Created by
admin on Fri Dec 15 15:30:44 GMT 2023 , Edited by admin on Fri Dec 15 15:30:44 GMT 2023
|
PRIMARY | |||
|
SUB11011MIG
Created by
admin on Fri Dec 15 15:30:44 GMT 2023 , Edited by admin on Fri Dec 15 15:30:44 GMT 2023
|
PRIMARY | |||
|
100000091864
Created by
admin on Fri Dec 15 15:30:44 GMT 2023 , Edited by admin on Fri Dec 15 15:30:44 GMT 2023
|
PRIMARY | |||
|
C021270
Created by
admin on Fri Dec 15 15:30:44 GMT 2023 , Edited by admin on Fri Dec 15 15:30:44 GMT 2023
|
PRIMARY | |||
|
251-329-3
Created by
admin on Fri Dec 15 15:30:44 GMT 2023 , Edited by admin on Fri Dec 15 15:30:44 GMT 2023
|
PRIMARY | |||
|
3320
Created by
admin on Fri Dec 15 15:30:44 GMT 2023 , Edited by admin on Fri Dec 15 15:30:44 GMT 2023
|
PRIMARY | |||
|
33005-95-7
Created by
admin on Fri Dec 15 15:30:44 GMT 2023 , Edited by admin on Fri Dec 15 15:30:44 GMT 2023
|
PRIMARY | |||
|
DB01600
Created by
admin on Fri Dec 15 15:30:44 GMT 2023 , Edited by admin on Fri Dec 15 15:30:44 GMT 2023
|
PRIMARY | |||
|
TIAPROFENIC ACID
Created by
admin on Fri Dec 15 15:30:44 GMT 2023 , Edited by admin on Fri Dec 15 15:30:44 GMT 2023
|
PRIMARY | |||
|
38253
Created by
admin on Fri Dec 15 15:30:44 GMT 2023 , Edited by admin on Fri Dec 15 15:30:44 GMT 2023
|
PRIMARY | |||
|
CHEMBL365795
Created by
admin on Fri Dec 15 15:30:44 GMT 2023 , Edited by admin on Fri Dec 15 15:30:44 GMT 2023
|
PRIMARY | |||
|
5468
Created by
admin on Fri Dec 15 15:30:44 GMT 2023 , Edited by admin on Fri Dec 15 15:30:44 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |